Biotech Values

[LongRun8]

I saw that, too.

In that article it says that Gladstone Institutes is reaching out to Vertex about getting access to that drug for clinical testing. If it truly looks like that failed seizure drug can lead to a new potential HIV drug, I have to imagine that Vertex would rather do the clinical trials themselves rather than letting Gladstone do it, no? Gladstone is a non-profit organization with, what I imagine, would be a lot fewer resources than Vertex. Maybe Vertex would pay Gladstone Inst. for their novel idea and then do all the research themselves. Or maybe they don't have to pay Gladstone at all? I'm not sure how that whole thing would work given it was Gladstone's idea but Vertex's drug.